Trials / Completed
CompletedNCT04473742
Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the efferocytosis capacities of blood Monocyte Derived Macrophages (MDM) from patients with a history of asbestosis or silica exposure and comparison of these capacities with those of MDM from healthy donors.
Detailed description
Patients with a proven history or current exposure will have 4 EDTA tubes drawn, approximately 24mL of fresh whole blood for efferocytosis assessment and : * 2 x 6mL serum tubes for the assessment of Antinuclear Antibody (ANA) positivity, serum high-mobility group box 1 (HMGB1) and osteopontin for patients exposed to asbestos * 1 x 6mL serum tube for serum HMGB1 and osteopontin for patients exposed to silica
Conditions
- History of Exposure to Silica or Asbestosis
- Positive Testing for ANA as a Marker of Systemic Autoimmune Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood collection | 4 EDTA tubes for 24 mL blood collection |
| BIOLOGICAL | Blood sample | 2 drying tubes for 12 mL blood collection |
| BIOLOGICAL | Blood sample | 1 drying tube for 6 mL blood collection |
Timeline
- Start date
- 2021-03-31
- Primary completion
- 2021-12-15
- Completion
- 2021-12-15
- First posted
- 2020-07-16
- Last updated
- 2022-01-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04473742. Inclusion in this directory is not an endorsement.